EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner

Xiaozhou Zou, Ting Liu, Zhongjie Huang, Wei Zhou, Mengnan Yuan, Hongying Zhao, Zongfu Pan, Pengcheng Chen, Yanfei Shao, Xiaoping Hu, Su Zhang, Shuilian Zheng und 2 weitere

Advanced Science · 2023

DOI: 10.1002/advs.202206139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Xiaozhou Zou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Me…. Hauptthemen laut MEDLINE: Exosomes, Hypertension, Pulmonary, MicroRNAs. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation of China, Medical and Health Research Program of Zhejiang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial dysfunction is considered a predominant driver for pulmonary vascular remodeling in pulmonary hypertension (PH). SOX17, a key regulator of vascular homoeostasis, has been found to harbor mutations in PH patients, which are associated with PH susceptibility. Here, this study explores whether SOX17 mediates the autocrine activity of pulmonary artery ECs to maintain endothelial function and vascular homeostasis in PH and its underlying mechanism. It is found that SOX17 expression is downregulated in the endothelium of remodeled pulmonary arteries in IPH patients and SU5416/hypoxia (Su/hypo)‐induced PH mice as well as dysfunctional HPAECs. Endothelial knockdown of SOX17 accelerates the progression of Su/hypo‐induced PH in mice. SOX17 overexpression in the pulmonary endothelium of mice attenuates Su/hypo‐induced PH. SOX17‐associated exosomes block the proliferation, apoptosis, and inflammation of HPAECs, preventing pulmonary arterial remodeling and Su/hypo‐induced PH. Mechanistic analyses demonstrates that overexpressing SOX17 promotes the exosome‐mediated release of miR‐224‐5p and miR‐361‐3p, which are internalized by injured HPAECs in an autocrine manner, ultimately repressing the upregulation of NR4A3 and PCSK9 genes and improving endothelial function. These results suggest that SOX17 is a key gene in maintaining endothelial function and vascular homeostasis in PH through regulating exosomal miRNAs in an autocrine manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesHypertension, PulmonaryMicroRNAsAnimalsHumansMiceEndothelial CellsEndotheliumHMGB ProteinsHypoxiaProprotein Convertase 9SOXF Transcription Factors

Stichwörter der Autor:innen

endothelium dysfunctionexosomesmiRNAspulmonary hypertensionsry-related high mobility group domain family F 17

Substanzen

HMGB ProteinsMicroRNAsPCSK9 protein, humanProprotein Convertase 9Sox17 protein, mouseSOXF Transcription FactorsSOX17 protein, human

Autor:innen und Institutionen

  • Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, P. R. China.
  • Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, 310014, P. R. China.
  • Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, P. R. China.
  • Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou…
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310014, P. R. China.
  • Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, 430000, P. R.…

ORCID-Profile: Ping Huang

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Province Natural Science Foundation of China
  • Medical and Health Research Program of Zhejiang
  • Chinese Medicine Research Program of Zhejiang Province
  • Adjunct Talent Fund of Zhejiang Provincial People's Hospital
  • Hospital Pharmacy Program of Zhejiang Provincial Pharmaceutical Association
  • "Ten thousand People Plan" Science and Technology Innovation Leading Talent Project of Zhejiang Province

Zitieren

APA

Zou, X., Liu, T., Huang, Z., Zhou, W., Yuan, M., Zhao, H., Pan, Z., Chen, P., Shao, Y., Hu, X., Zhang, S., Zheng, S., Zhang, Y., & Huang, P. (2023). SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner. Advanced Science. https://doi.org/10.1002/advs.202206139

Vancouver

Zou X, Liu T, Huang Z, Zhou W, Yuan M, Zhao H, et al. SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner. Advanced Science. 2023. doi:10.1002/advs.202206139

BibTeX
@article{Zou2023,
  author = {Zou, Xiaozhou and Liu, Ting and Huang, Zhongjie and Zhou, Wei and Yuan, Mengnan and Zhao, Hongying and Pan, Zongfu and Chen, Pengcheng and Shao, Yanfei and Hu, Xiaoping and Zhang, Su and Zheng, Shuilian and Zhang, Yiwen and Huang, Ping},
  title = {SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202206139}
}
Kostenlos starten →